Accessibility Menu
 
National Research logo

National Research

(NASDAQ) NRC

Current Price$17.10
Market Cap$398.52M
Since IPO (2013)+12%
5 Year-58%
1 Year+27%
1 Month+34%

National Research Financials at a Glance

Market Cap

$398.52M

Revenue (TTM)

$137.39M

Net Income (TTM)

$11.60M

EPS (TTM)

$0.50

P/E Ratio

34.96

Dividend

$0.52

Beta (Volatility)

0.67 (Low)

Price

$17.10

Volume

47,417.544

Open

$17.35

Previous Close

$17.13

Daily Range

$16.84 - $17.44

52-Week Range

$9.76 - $22.79

NRC: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About National Research

Industry

Healthcare Providers and Services

Employees

357

CEO

Trent Green, MBA

Headquarters

Lincoln, NE 68508, US

NRC Financials

Key Financial Metrics (TTM)

Gross Margin

56%

Operating Margin

16%

Net Income Margin

8%

Return on Equity

50%

Return on Capital

23%

Return on Assets

9%

Earnings Yield

2.86%

Dividend Yield

0.03%

Payout Ratio

94.65%

Stock Overview

Market Cap

$398.52M

Shares Outstanding

22.75M

Volume

47.42K

Short Interest

0.00%

Avg. Volume

107.86K

Financials (TTM)

Gross Profit

$77.39M

Operating Income

$22.59M

EBITDA

$30.23M

Operating Cash Flow

$26.45M

Capital Expenditure

$10.71M

Free Cash Flow

$15.74M

Cash & ST Invst.

$4.14M

Total Debt

$79.03M

National Research Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$35.19M

-4.6%

Gross Profit

$19.11M

-15.3%

Gross Margin

54.31%

N/A

Market Cap

$398.52M

N/A

Market Cap/Employee

$1.08M

N/A

Employees

368

N/A

Net Income

$1.80M

-72.6%

EBITDA

$6.78M

-39.0%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$74.90M

-24.5%

Accounts Receivable

$11.11M

-0.8%

Inventory

$0.00

N/A

Long Term Debt

$75.02M

+27.0%

Short Term Debt

$4.01M

-25.0%

Return on Assets

8.60%

N/A

Return on Invested Capital

22.99%

N/A

Free Cash Flow

$6.06M

+213.1%

Operating Cash Flow

$7.18M

+12.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VMDViemed Healthcare, Inc.
$9.25+0.33%
SOPHSOPHiA GENETICS S.A.
$4.70-0.63%
PBYIPuma Biotechnology, Inc.
$6.08-3.03%
SPOKSpok Holdings, Inc.
$11.08-0.45%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%
ARTLArtelo Biosciences
$10.54+2.30%

Questions About NRC

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.